Sovaldi – A Breakthrough Treatment for Chronic Hepatitis C Virus (HCV)
Short general description of Sovaldi Sovaldi, also known as Sofosbuvir, is a breakthrough antiviral medication used for the treatment of chronic hepatitis C virus (HCV) infection. It is produced by Gilead Sciences and was approved by the U.S. Food and Drug Administration (FDA) in December 2013. Sovaldi has revolutionized the treatment of hepatitis C, offering…